A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes
A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes. // HPB. – URL: https://www.sciencedirect.com/science/article/pii/S1365182X26028121?dgcid=rss_sd_all
A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes. HPB. https://www.sciencedirect.com/science/article/pii/S1365182X26028121?dgcid=rss_sd_all
“A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.” HPB.
@article{article48266,
title = {A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes},
journal = {HPB},
url = {https://www.sciencedirect.com/science/article/pii/S1365182X26028121?dgcid=rss_sd_all}
}